Department of Medicine

The University of Vermont Cancer Center now offers a novel, highly effective form of cancer treatment called CAR T-cell therapy, and recently began treating patients. The Cancer Center is the only health care institution in Vermont and northern New York to provide the treatment.

A new study published in JAMA Cardiology by UVM cardiovascular medicine fellow Margaret Infeld, M.D., M.S., and colleagues found evidence that by implementing a tailored acceleration of heart rates, they could reduce congestion and improve the circulation of blood in heart failure patients with "stiff" hearts.

Randall F. Holcombe, M.D., M.B.A., director of the UVM Cancer Center and chief of the Division of Hematology and Oncology in the Department of Medicine, has been appointed as associate dean for cancer programs at the UVM Larner College of Medicine.

(FEBRUARY 17, 2023) Diego Adrianzen Herrera, M.D., assistant professor of medicine, commented to Medscape on a study of postremission therapy in patients with intermediate-risk acute myeloid leukemia (AML) that was published online in JAMA Oncology.

Sherrie Khadanga, M.D., M.S., assistant professor of medicine at UVM's Larner College of Medicine and assistant director of cardiac rehabilitation at the UVM Medical Center, was recently featured in a UVM Health Network HealthSource blog post titled "Women Find Strength with Cardiac Rehab" that focused on how High-Intensity Interval Training (HIIT) exercise can help women's recovery after a cardiac event.